# An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis

> **NCT06627335** · — · RECRUITING · sponsor: **Incyte Corporation** · enrollment: 5621 (estimated)

## Conditions studied

- Pregnancy Related
- Atopic Dermatitis

## Interventions

- **DRUG:** Ruxolitinib Cream
- **DRUG:** TCS

## Key facts

- **NCT ID:** NCT06627335
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-27
- **Primary completion:** 2027-08-15
- **Final completion:** 2028-08-15
- **Target enrollment:** 5621 (ESTIMATED)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06627335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06627335, "An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06627335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*